Pradaxa and Dabigatran
Type of Spiritual Experience
A description of the experience
Dabigatran (Pradaxa in Australia, Canada, Europe and USA, Prazaxa in Japan) is an oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant ("blood thinner") since it does not require blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy. There is no specific way to reverse the anticoagulant effect of dabigatran in the event of a major bleeding event, unlike warfarin, although a potential dabigatran antidote (pINN: idarucizumab) is undergoing clinical studies. It was developed by the pharmaceutical company Boehringer Ingelheim.
On Dec, 23, 2016 51,291 people reported to have side effects when taking Pradaxa.
Among them, 72 people (0.14%) have Hallucination
Time on Pradaxa when people have Hallucination :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years|
Gender of people who have Hallucination when taking Pradaxa :
Age of people who have Hallucination when taking Pradaxa :
Severity of Hallucination when taking Pradaxa :
How people recovered from Hallucination :
|while on the drug||after off the drug||not yet|